Medical Sessions
Scientific and Clinical Sessions for
Physicians, Researchers, Registered Nurses,
and Allied Health Professionals
Scientific Sessions
Lung Injury and Repair
Leader: Gregory P. Cosgrove, MD
Introduction, Daniel M. Rose, MD and Gregory P. Cosgrove, MD
IPF−What’s Age Got to Do With It?, Joseph Lasky, MD
A Stressful Environment Leading to Epithelial Injury, Timothy S. Blackwell, MD
Fibroblasts and Extracellular Matrix: Too Much of a Good Thing?, Eric S. White, MD
Mediators of the Fibroproliferative Injury−Interactions Between the Epithelium and Fibroblast, Andrew Tager, MD
Genetics and Biomarkers
Leaders: Imre Noth, MD and Christine Garcia, MD, PhD
Panel: Naftali Kaminski, MD and David A. Schwartz, MD
Defining the Challenges – What Biomarkers Do We Need?, Imre Noth, MD
The Genetic Basis of IPF, David A. Schwartz, MD
Blood Based Biomarkers to Diagnose and Predict Outcome of IPF, Naftali Kaminski, MD
From Bench to Bedside—An Investigator’s Personal Perspective on Taking a Basic Finding
to the Real World of Patient Management, Kenneth Adler, PhD
Biomarkers for Disease Activity: Designing Drug Studies and Managing Patients,
Fernando J. Martinez, MD, MS
Beyond Rales: Are We Really There Yet?, Christine Garcia, MD, PhD
Drug Development in IPF
Leaders: Bruce Montgomery, MD; Harold R. Collard, MD; and Kevin K. Brown, MD
Drug Development in IPF: Lessons Learned from Phase III Clinical Trials,
Bruce Montgomery, MD
Drug Development in IPF: From the Bedside to Approval, Marianne Mann, MD
Clinical Sessions
Clinical Lung Injury and Repair
Leader: Jeffrey J. Swigris, DO, M
Establishing a Confident Diagnosis, Kevin R. Flaherty, MD, MS
Connective Tissue Fibrotic Disorders, Aryeh Fischer, MD
Pulmonary Hypertension, David A. Zisman, MD
Treatment Options, Kevin K. Brown, MD; Ganesh Raghu, MD; and
Marvin I. Schwarz, MD
Case Presentations with Master Clinicians, Kevin K. Brown, MD; Ganesh Raghu, MD;
Marvin I. Schwarz, MD; Talmadge E. King, Jr, MD; Aliya N.
Husain, MD; and John David Armstrong, MD
Update on Transplantation
Leader: Robert Love, MD
Recent Trends and Results, Kenneth McCurry, MD
Treatment of Acute Rejections and BOS, Timothy P. Whelan, MD
Ex-Vivo Perfusion, Robert Love, MD
Update on ECMO, Charles Hoopes, MD



